Biogen Inc.
BIIB · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $22,280,444 | $37,444,019 | $40,236,476 | $35,772,072 |
| - Cash | $2,375,000 | $1,049,900 | $3,419,300 | $2,261,400 |
| + Debt | $6,630,300 | $7,338,200 | $6,614,000 | $7,603,500 |
| Enterprise Value | $26,535,744 | $43,732,319 | $43,431,176 | $41,114,172 |
| Revenue | $9,675,900 | $9,835,600 | $10,173,400 | $10,981,700 |
| % Growth | -1.6% | -3.3% | -7.4% | – |
| Gross Profit | $7,365,500 | $7,302,200 | $7,895,100 | $8,872,000 |
| % Margin | 76.1% | 74.2% | 77.6% | 80.8% |
| EBITDA | $2,995,700 | $2,377,000 | $3,536,900 | $3,923,400 |
| % Margin | 31% | 24.2% | 34.8% | 35.7% |
| Net Income | $1,632,200 | $1,161,100 | $3,046,900 | $1,556,100 |
| % Margin | 16.9% | 11.8% | 29.9% | 14.2% |
| EPS Diluted | 11.19 | 7.97 | 20.87 | 10.4 |
| % Growth | 40.4% | -61.8% | 100.7% | – |
| Operating Cash Flow | $2,875,500 | $1,547,200 | $1,384,300 | $3,639,900 |
| Capital Expenditures | -$359,800 | -$311,400 | -$240,300 | -$258,100 |
| Free Cash Flow | $2,515,700 | $1,235,800 | $1,144,000 | $3,381,800 |